The ONCOCAMP Study

Last updated: July 24, 2025
Sponsor: National Cancer Institute, Naples
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasms

Cancer

Treatment

Data collection (prospective)

Data collection (retrospective)

Clinical Study ID

NCT06270602
ONCOCAMP
6/23 oss
  • Ages > 18
  • All Genders

Study Summary

The present study is a retrospective-prospective observational and multicentric study aiming to collect data relating to all patients included in the ROC platform. All ROC centers will be involved in the present study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • signed informed consent

  • registration in the ROC platform

Study Design

Total Participants: 15000
Treatment Group(s): 2
Primary Treatment: Data collection (prospective)
Phase:
Study Start date:
July 14, 2023
Estimated Completion Date:
July 31, 2026

Study Description

The ROC platform therefore represents a multicenter database and a growing source of data and information regarding cancer patients in the Campania region. The need for multicenter databases is supported by the results obtained with both retrospective and prospective studies. Many retrospective studies have led to changes in some of the available guidelines. Important advantages of this study include representativeness of the analyzed cohort to all patients with a specific cancer and a large sample size that provides sufficient statistical power to detect differences across different patient groups. The data extracted from the ROC have the potential to produce knowledge, to guide decision-making, and to manage more effectively the challenges of fighting cancer in our region. The Campania region counts more than 6 million people, and it is characterized by a worst oncological outcome compared to the average data of other Italian region: the ROC platform has the potential to analyze the effect of a public intervention in the field of oncology care. Therefore, the primary aim of this study is to create a retrospective-prospective registry of all cancer patients entering the ROC platform and in a GOM path describing the primary and secondary endpoints.

Connect with a study center

  • Asl Napoli 2 Nord

    Casavatore, Napoli 80020
    Italy

    Active - Recruiting

  • Asl Napoli 3 Sud

    Ercolano, Napoli 80056
    Italy

    Active - Recruiting

  • A.O. Moscati

    Avellino, 83100
    Italy

    Active - Recruiting

  • Asl Avellino

    Avellino, 83100
    Italy

    Active - Recruiting

  • A.O. Rummo

    Benevento, 82100
    Italy

    Active - Recruiting

  • Asl Benevento

    Benevento, 82100
    Italy

    Active - Recruiting

  • A.O. S.Anna S. Sebastiano

    Caserta, 81100
    Italy

    Active - Recruiting

  • Asl Caserta

    Caserta, 81035
    Italy

    Active - Recruiting

  • A.O. Cardarelli

    Napoli, 80131
    Italy

    Active - Recruiting

  • A.O. Dei Colli

    Napoli, 80131
    Italy

    Active - Recruiting

  • A.O.U. Luigi Vanvitelli

    Napoli, 80138
    Italy

    Active - Recruiting

  • Asl Napoli 1 Centro

    Napoli, 80145
    Italy

    Active - Recruiting

  • Federico II

    Napoli, 80131
    Italy

    Active - Recruiting

  • I.N.T. Pascale

    Napoli, 80131
    Italy

    Active - Recruiting

  • Ospedale del Mare

    Napoli, 80147
    Italy

    Active - Recruiting

  • A.O.U. Ruggi

    Salerno, 84126
    Italy

    Active - Recruiting

  • Asl Salerno

    Salerno, 84124
    Italy

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.